Cart
sales@molnova.com
WHI-P258
CAS No. 21561-09-1
WHI-P258( WHI-P258 | WHI-P 258 | WHI-P-258 | WHIP 258 )
Catalog No. M13440 CAS No. 21561-09-1
WHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 32 | In Stock |
|
| 5MG | 28 | In Stock |
|
| 10MG | 46 | In Stock |
|
| 25MG | 88 | In Stock |
|
| 50MG | 137 | In Stock |
|
| 100MG | 233 | In Stock |
|
| 200MG | 341 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWHI-P258
-
NoteResearch use only, not for human use.
-
Brief DescriptionWHI-P258 is a dimethoxyquinazoline inhibitor of JAK3.
-
DescriptionWHI-P258 is a dimethoxyquinazoline inhibitor of JAK3. This compound binds JAK3 weakly and may be used as a JAK binding negative control in the development of new therapeutics.
-
In Vitro——
-
In Vivo——
-
SynonymsWHI-P258 | WHI-P 258 | WHI-P-258 | WHIP 258
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorEGFR| JAK3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number21561-09-1
-
Formula Weight281.31
-
Molecular FormulaC16H15N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: <1.2mg/mL
-
SMILESCOC1=CC2=NC=NC(NC3=CC=CC=C3)=C2C=C1OC
-
Chemical Name6,7-Dimethoxy-N-phenylquinazolin-4-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fry DW, et al. Science. 1994, 265(5175), 1093-1095.
molnova catalog
related products
-
AZD8931 diFuMaric ac...
AZD8931 is a reversible and ATP competitive inhibitor of EGFR, ErbB2 and ErbB3 (IC50 of 4 nM, 3 nM and 4 nM, respectively).AZD8931 significantly suppressed cell growth of IBC cells and induced apoptosis of human IBC cells in vitro.AZD8931 monotherapy inhibited xenograft growth.
-
EGF816 mesylate
EGF816 (Nazartinib) is a potent, irreversible, mutant-selective EGFR inhibitor with Ki and Kinact of 31 nM and 0.222 min-1, respectively.
-
Tyrphostin B44, (+) ...
Tyrphostin B44, (+) enantiomer is an inhibitor of epidermal growth factor receptor (EGFR) kinase with IC50 of 0.86 μM and has less active than the (-) enantiomer.
